申请人:Hoechst Aktiengesellschaft
公开号:US05006515A1
公开(公告)日:1991-04-09
Pharmaceuticals containing or composed of at least one compound of the formula I and/or one of its physiologically tolerated salts where appropriate, where the compounds of the formula I can, where appropriate, be in the form of pure stereoisomers or mixtures thereof; formula I is: ##STR1## in which R.sup.1 =organic radical or halogen, A=C,C single or C,C double bond, n=0, 1 or 2, and ##STR2## R.sup.2 and R.sup.3 =H or optionally substituted aliphatic radical. The pharmaceuticals are suitable for the prophylaxis and/or treatment of diseases of the immune system, especially of tumors, infections and/or autoimmune diseases of the human or animal body and for use as adjuvants for vaccines. Some of the compounds of the formula I are new; the compounds can be prepared by special processes.
该药物含有或由至少一种式I的化合物和/或其生理耐受的盐组成,其中适当时,式I的化合物可以以纯立体异构体形式或其混合物形式存在;式I为:##STR1##其中R.sup.1 =有机基团或卤素,A=C、C单键或C、C双键,n=0、1或2,以及##STR2##R.sup.2和R.sup.3 =H或可选择性取代的脂肪基团。该药物适用于预防和/或治疗免疫系统疾病,特别是人体或动物体内的肿瘤、感染和/或自身免疫疾病,并可用作疫苗佐剂。其中一些式I的化合物是新的;这些化合物可以通过特殊的工艺制备。